Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.91 |
| ▸ | BLM | P54132 | 1/20 | 0.91 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.91 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | INPPL1 | O15357 | 2/20 | 0.35 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.35 |
| ▸ | INPP5B | P32019 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.35 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.33 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL134995 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL57948 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL9491121 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL8817259 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL14956573 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL1859412 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL396637 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL23410734 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL22587425 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL9744025 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104902-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE PALATABILITY OF DRY DOG FOOD | SOCIETE DES PRODUITS NESTLE SA (CH) | 2026-05-21 | — | — | WO | claimed |
| US-20260137104-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE PALATABILITY OF DRY DOG FOOD | Société des Produits Nestlé S.A. (CH) | 2026-05-21 | — | — | US | claimed |
| EP-4611098-A1 | SOLID ELECTROLYTE AND ELECTRODE FOR A SOLID-STATE BATTERY COMPRISING FUNCTIONAL FILLERS AND DISPERSING AGENTS, AND METHODS FOR PRODUCING THE SAME | SOLiTHOR (BE) | 2025-09-03 | — | — | EP | claimed |
| CN-115845782-B | Production method of high-solubility sodium-potassium crosslinked modified phosphate | 湖北省兴发磷化工研究院有限公司 | 2025-06-24 | — | — | CN | claimed |
| EP-3065557-B2 | DRY PET FOOD COMPRISING A PALATABILITY ENHANCING COATING | MARS INC (US) | 2025-03-26 | — | — | EP | claimed |
| US-20240277007-A1 | DRY PET FOOD COMPRISING A PALATABILITY ENHANCING COATING | MARS, INCORPORATED (US) | 2024-08-22 | — | — | US | claimed |
| US-12054689-B2 | Composition for lubricating and/or descaling during hot working of metals | CHEMISCHE FABRIK BUDENHEIM KG (DE) | 2024-08-06 | — | — | US | claimed |
| EP-3197420-B1 | ORAL CARE COMPOSITION CONTAINING ZINC SALTS AND CALCIUM CARBONATE | COLGATE PALMOLIVE CO (US) | 2024-04-03 | — | — | EP | claimed |
| CN-117070405-A | Pseudomonas taiwanensis ZJPH2023032 and application thereof in preparation of (R) -2-chloropropionic acid | 浙江工业大学 | 2023-11-17 | — | — | CN | claimed |
| US-20230357662-A1 | COMPOSITION FOR LUBRICATING AND/OR DESCALING DURING HOT WORKING OF METALS | CHEMISCHE FABRIK BUDENHEIM KG (DE) | 2023-11-09 | — | — | US | claimed |
| EP-1047760-A1 | GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-02 | — | — | EP | claimed |
| EP-1047767-A1 | GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-02 | — | — | EP | claimed |
| EP-1040819-A2 | Oral compositions comprising a potassium salt for reducing dental nerve and dentin sensitivity | Pfizer Products Inc. (US) | 2000-10-04 | — | — | EP | claimed |
| EP-1021508-A1 | MID-CHAIN BRANCHED SURFACTANTS WITH POTASSIUM IONS | THE PROCTER & GAMBLE CELLULOSE COMPANY (an Ohio corp.) (US) | 2000-07-26 | — | — | EP | claimed |
| WO-1999036494-A1 | GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-22 | — | — | WO | claimed |
| WO-1999036503-A1 | GRANULAR COMPOSITIONS HAVING IMPROVED DISSOLUTION | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-22 | — | — | WO | claimed |
| WO-1999019443-A1 | MID-CHAIN BRANCHED SURFACTANTS WITH POTASSIUM IONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-22 | — | — | WO | claimed |
| EP-0881938-A4 | NOVEL METHODS AND APPARATUS FOR OSMOTIC DISTILLATION | RENTIERS MACHINERY PTY LTD (AU) | 1999-04-14 | — | — | EP | claimed |
| EP-0881938-A1 | NOVEL METHODS AND APPARATUS FOR OSMOTIC DISTILLATION | Rentiers Machinery Proprietary Ltd. (AU) | 1998-12-09 | — | — | EP | claimed |
| US-5824223-A | Methods and apparatus for osmotic distillation | RENTIERS MACHINERY PROPRIETARY LTD. (AU) | 1998-10-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137104-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE PALATABILITY OF DRY DOG FOOD | PLCD1, PLCB3, PLCG2 | FDPS 611/4885BLM 4278/4885TDP1 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.